Bill Szablewski
Head of Capital Markets and Investor RelationsViatris
PharmaceuticalsView Profile →Senior Vice President, Financial Planning and Analysis · Regeneron Pharmaceuticals
Zoran Berkovic is senior vice president of financial planning and analysis at Regeneron Pharmaceuticals. He joined in 2017 after finance responsibilities at Mylan and Cephalon, including a regional CFO role covering Japan, Australia and New Zealand.
Last reviewed: Oct 21, 2026
Senior Vice President, Financial Planning and Analysis Regeneron Pharmaceuticals
Last Reviewed: October 21, 2026
Zoran Berkovic is senior vice president of financial planning and analysis at Regeneron Pharmaceuticals. He joined in 2017 after finance responsibilities at Mylan and Cephalon, including a regional CFO role covering Japan, Australia and New Zealand.
Berkovic’s career developed in the finance functions of pharmaceutical companies. Before Regeneron, he worked in financial roles at Cephalon and later at Mylan, where his responsibilities included serving as regional chief financial officer for Japan, Australia and New Zealand. The company biography also describes other Mylan roles without assigning titles or dates.
He joined Regeneron in 2017 and now serves as senior vice president of financial planning and analysis. The company describes an expansion in the scope of the planning group during his tenure, together with a focus on accountability. That experience combines regional finance leadership with a corporate planning position within a research-driven pharmaceutical organization.
His earlier CFO position is part of his career history; his current office is financial planning and analysis rather than chief financial officer. The reviewed primary biography does not specify his promotion date to senior vice president or identify the individual business portfolios covered by his earlier finance assignments.
Berkovic holds an MBA from Temple University. Regeneron also reports BS and BBA qualifications in finance and economics earned outside the United States, but does not name the undergraduate institutions; those institutions are not inferred.